Vivo Capital IX, LLC, 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS), sold 10,748 shares at $12.25 ($132K) on 2022-05-05, disclosed to the SEC on 2022-05-05.
Open-market sale of $132k TARS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.25 | 5,374 | $66K | 50.0% |
| 2 | $12.25 | 5,374 | $66K | 50.0% |
| Total | $12.25 avg | 10,748 | $132K | 100% |
| Filing → |
| TARS | SELL | 2021-06-25 | $1.9M | — | Filing → |
| TARS | SELL | 2021-04-16 | $12K | — | Filing → |